Novel atomic level predictive bioanalytics that integrate heterogeneous data sources to identify multiscale biological relationships of compound proteome interactions combined with other emerging technologies foreshadows a new era of faster, safer, better and cheaper drug repurposing and discovery. CANDO and the infinite drug discovery frontier